Who Owns Voyager Therapeutics Stock?
NASDAQ: VYGRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 57.92%
- Held by insiders
- 14.84%
- Institutional holders
- 180
- Institutions 57.9%
- Insiders 14.8%
- Public and other 27.2%
Who owns Voyager Therapeutics stock?
Institutional investors own about 57.9% of Voyager Therapeutics's shares, spread across 180 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 14.84% of VYGR.
The largest institutional holders are Blackrock Inc. (8.39%), Millennium Management Llc (7.21%) and Armistice Capital, LLC (5.58%). Together, the top 10 institutions control 38.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their VYGR positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VYGR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 5.17M | 8.39% | -7.1% |
| Millennium Management Llc | 4.44M | 7.21% | +29.6% |
| Armistice Capital, LLC | 3.44M | 5.58% | -1.8% |
| Vestal Point Capital, LP | 2.63M | 4.26% | -12.6% |
| Vanguard Capital Management LLC | 2.35M | 3.81% | +2.7% |
| Geode Capital Management, LLC | 1.33M | 2.16% | +26.7% |
| Opaleye Management Inc. | 1.19M | 1.92% | +3.0% |
| State Street Corporation | 1.08M | 1.75% | +13.5% |
| Two Sigma Investments, LP | 948.52K | 1.54% | +54.1% |
| Dimensional Fund Advisors LP | 838.18K | 1.36% | -4.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VYGR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.67M | 2.71% |
| iShares Trust-iShares Russell 2000 ETF | 1.36M | 2.20% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 613.13K | 1.00% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 570.44K | 0.93% |
| iShares Trust-iShares Russell 2000 Value ETF | 484.77K | 0.79% |
| Vanguard Explorer Fund | 457.06K | 0.74% |
| iShares Trust-iShares Biotechnology ETF | 368.06K | 0.60% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 280.17K | 0.45% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 240.08K | 0.39% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 225.28K | 0.37% |
Frequently asked questions
Who is the largest shareholder of Voyager Therapeutics?
Blackrock Inc. is the largest institutional shareholder of VYGR, owning 8.39% of shares outstanding (5.17M shares) as of its latest 13F filing.
What percentage of Voyager Therapeutics is owned by institutions?
Institutions own about 57.9% of VYGR shares and 68.0% of the public float.
How much of Voyager Therapeutics do insiders own?
Insiders, such as officers and directors, own about 14.84% of VYGR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.